跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 77 条关于
“CLN5”
全部
77
临床试验
50
药物
16
机构
0
资讯
11
去年
NCL Translational Research Conference Highlights Advances in Batten Disease Therapies
2年前
FDA Expands Brineura Approval to Include All Ages with CLN2 Disease
去年
Novel Nanoparticle Therapy Agg-CLNP Shows Promise for Preventing Rheumatoid Arthritis and Reducing Flares
去年
NICE Extends Access to Brineura for CLN2 Batten Disease While Seeking Long-term Solution
上个月
New Retina Model Reveals How CLN3-Batten Disease Damages Vision and Points to a Treatment
去年
Andelyn Biosciences Partners with Tern Therapeutics for Late-Stage Manufacturing of CLN2 Batten Disease Gene Therapy
2年前
Cullinan Therapeutics Advances CLN-978 for SLE Treatment with Phase 1 Trial Approval
9个月前
Latus Bio Receives FDA IND Clearance for LTS-101 Gene Therapy to Treat Fatal CLN2 Disease in Children
4年前
Cullinan Oncology and Taiho Pharmaceutical Forge $275M Strategic Collaboration for EGFR Inhibitor CLN-081/TAS6417
11个月前
Cullinan Therapeutics Reports Promising 30% Response Rate for CLN-049 T Cell Engager in Relapsed AML Patients
第 1 页,共 2 页
上一页
下一页